Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 1722 entries
Sorted by: Best Match Show Resources per page
Imprudent Gastro-protective Approach in Majority of Specialists' Clinics of a Tertiary Hospital.

Journal of clinical and diagnostic research : JCDR

Patel HR, Dhande P.
PMID: 27134889
J Clin Diagn Res. 2016 Mar;10(3):FC12-5. doi: 10.7860/JCDR/2016/16976.7499. Epub 2016 Mar 01.

INTRODUCTION: One out of four prescriptions in out-patient departments contains a gastro-protective drug (APUD) - PPI/ H2 Blockers/ Antacids/ Ulcer Protective's. These drugs should be prescribed only when there is a justified indication. To assess the prescriptions of gastro-protective...

Cite
Patel HR, Dhande P. Imprudent Gastro-protective Approach in Majority of Specialists' Clinics of a Tertiary Hospital. J Clin Diagn Res. 2016;10(3):FC12-5doi: 10.7860/JCDR/2016/16976.7499.
Patel, H. R., & Dhande, P. (2016). Imprudent Gastro-protective Approach in Majority of Specialists' Clinics of a Tertiary Hospital. Journal of clinical and diagnostic research : JCDR, 10(3), FC12-5. https://doi.org/10.7860/JCDR/2016/16976.7499
Patel, Hardik Rameshbhai, and Dhande, Priti. "Imprudent Gastro-protective Approach in Majority of Specialists' Clinics of a Tertiary Hospital." Journal of clinical and diagnostic research : JCDR vol. 10,3 (2016): FC12-5. doi: https://doi.org/10.7860/JCDR/2016/16976.7499
Patel HR, Dhande P. Imprudent Gastro-protective Approach in Majority of Specialists' Clinics of a Tertiary Hospital. J Clin Diagn Res. 2016 Mar;10(3):FC12-5. doi: 10.7860/JCDR/2016/16976.7499. Epub 2016 Mar 01. PMID: 27134889; PMCID: PMC4843275.
Copy Download .nbib Format: NLM
Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?.

Clinical and translational gastroenterology

Hunt RH, Scarpignato C.
PMID: 26513137
Clin Transl Gastroenterol. 2015 Oct 29;6:e119. doi: 10.1038/ctg.2015.39.

The need for new acid suppressing agents with improved pharmacology and superior antisecretory effects to address unmet clinical needs in acid-related disorders has been evident for over a decade. Recent new antisecretory drugs (IR-omeprazole and MR-dexlansoprazole) only provide a...

Cite
Hunt RH, Scarpignato C. Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?. Clin Transl Gastroenterol. 2015;6:e119doi: 10.1038/ctg.2015.39.
Hunt, R. H., & Scarpignato, C. (2015). Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?. Clinical and translational gastroenterology, 6e119. https://doi.org/10.1038/ctg.2015.39
Hunt, Richard H, and Scarpignato, Carmelo. "Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?." Clinical and translational gastroenterology vol. 6 (2015): e119. doi: https://doi.org/10.1038/ctg.2015.39
Hunt RH, Scarpignato C. Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?. Clin Transl Gastroenterol. 2015 Oct 29;6:e119. doi: 10.1038/ctg.2015.39. PMID: 26513137; PMCID: PMC4816037.
Copy Download .nbib Format: NLM
A retrospective analysis of the role of proton pump inhibitors in colorectal cancer disease survival.

Current oncology (Toronto, Ont.)

Graham C, Orr C, Bricks CS, Hopman WM, Hammad N, Ramjeesingh R.
PMID: 28050148
Curr Oncol. 2016 Dec;23(6):e583-e588. doi: 10.3747/co.23.3204. Epub 2016 Dec 21.

BACKGROUND: Proton pump inhibitors (ppis) are a commonly used medication. A limited number of studies have identified a weak-to-moderate association between ppi use and colorectal cancer (crc) risk, but none to date have identified an effect of ppi use...

Cite
Graham C, Orr C, Bricks CS, et al. A retrospective analysis of the role of proton pump inhibitors in colorectal cancer disease survival. Curr Oncol. 2016;23(6):e583-e588doi: 10.3747/co.23.3204.
Graham, C., Orr, C., Bricks, C. S., Hopman, W. M., Hammad, N., & Ramjeesingh, R. (2016). A retrospective analysis of the role of proton pump inhibitors in colorectal cancer disease survival. Current oncology (Toronto, Ont.), 23(6), e583-e588. https://doi.org/10.3747/co.23.3204
Graham, C, et al. "A retrospective analysis of the role of proton pump inhibitors in colorectal cancer disease survival." Current oncology (Toronto, Ont.) vol. 23,6 (2016): e583-e588. doi: https://doi.org/10.3747/co.23.3204
Graham C, Orr C, Bricks CS, Hopman WM, Hammad N, Ramjeesingh R. A retrospective analysis of the role of proton pump inhibitors in colorectal cancer disease survival. Curr Oncol. 2016 Dec;23(6):e583-e588. doi: 10.3747/co.23.3204. Epub 2016 Dec 21. PMID: 28050148; PMCID: PMC5176385.
Copy Download .nbib Format: NLM
Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry.

F1000Research

Long J, Wright E, Molesti E, Temperton N, Barclay W.
PMID: 26069727
F1000Res. 2015 Jan 29;4:30. doi: 10.12688/f1000research.6085.1. eCollection 2015.

Emerging viral diseases pose a threat to the global population as intervention strategies are mainly limited to basic containment due to the lack of efficacious and approved vaccines and antiviral drugs. The former was the only available intervention when...

Cite
Long J, Wright E, Molesti E, et al. Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry. F1000Res. 2015;4:30doi: 10.12688/f1000research.6085.1.
Long, J., Wright, E., Molesti, E., Temperton, N., & Barclay, W. (2015). Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry. F1000Research, 430. https://doi.org/10.12688/f1000research.6085.1
Long, Jason, et al. "Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry." F1000Research vol. 4 (2015): 30. doi: https://doi.org/10.12688/f1000research.6085.1
Long J, Wright E, Molesti E, Temperton N, Barclay W. Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry. F1000Res. 2015 Jan 29;4:30. doi: 10.12688/f1000research.6085.1. eCollection 2015. PMID: 26069727; PMCID: PMC4431382.
Copy Download .nbib Format: NLM
Gender differences in symptoms in partial responders to proton pump inhibitors for gastro-oesophageal reflux disease.

United European gastroenterology journal

Vakil N, Niklasson A, Denison H, Rydén A.
PMID: 26535123
United European Gastroenterol J. 2015 Oct;3(5):443-52. doi: 10.1177/2050640614558343.

BACKGROUND: Gender differences may exist in the symptom experience of patients with gastro-oesophageal reflux disease (GERD) who have a partial response to proton pump inhibitors (PPIs).OBJECTIVE: The purpose of this study was to analyse gender differences in partial responders...

Cite
Vakil N, Niklasson A, Denison H, et al. Gender differences in symptoms in partial responders to proton pump inhibitors for gastro-oesophageal reflux disease. United European Gastroenterol J. 2015;3(5):443-52doi: 10.1177/2050640614558343.
Vakil, N., Niklasson, A., Denison, H., & Rydén, A. (2015). Gender differences in symptoms in partial responders to proton pump inhibitors for gastro-oesophageal reflux disease. United European gastroenterology journal, 3(5), 443-52. https://doi.org/10.1177/2050640614558343
Vakil, N, et al. "Gender differences in symptoms in partial responders to proton pump inhibitors for gastro-oesophageal reflux disease." United European gastroenterology journal vol. 3,5 (2015): 443-52. doi: https://doi.org/10.1177/2050640614558343
Vakil N, Niklasson A, Denison H, Rydén A. Gender differences in symptoms in partial responders to proton pump inhibitors for gastro-oesophageal reflux disease. United European Gastroenterol J. 2015 Oct;3(5):443-52. doi: 10.1177/2050640614558343. PMID: 26535123; PMCID: PMC4625745.
Copy Download .nbib Format: NLM
Clinical relevance of clopidogrel-proton pump inhibitors interaction.

World journal of gastrointestinal pharmacology and therapeutics

Bouziana SD, Tziomalos K.
PMID: 25949846
World J Gastrointest Pharmacol Ther. 2015 May 06;6(2):17-21. doi: 10.4292/wjgpt.v6.i2.17.

Clopidogrel is a widely used antiplatelet agent for the secondary prevention of cardiovascular events in patients with stable coronary heart disease, acute coronary syndromes and ischemic stroke. Even though clopidogrel is safer than aspirin in terms of risk for...

Cite
Bouziana SD, Tziomalos K. Clinical relevance of clopidogrel-proton pump inhibitors interaction. World J Gastrointest Pharmacol Ther. 2015;6(2):17-21doi: 10.4292/wjgpt.v6.i2.17.
Bouziana, S. D., & Tziomalos, K. (2015). Clinical relevance of clopidogrel-proton pump inhibitors interaction. World journal of gastrointestinal pharmacology and therapeutics, 6(2), 17-21. https://doi.org/10.4292/wjgpt.v6.i2.17
Bouziana, Stella D, and Tziomalos, Konstantinos. "Clinical relevance of clopidogrel-proton pump inhibitors interaction." World journal of gastrointestinal pharmacology and therapeutics vol. 6,2 (2015): 17-21. doi: https://doi.org/10.4292/wjgpt.v6.i2.17
Bouziana SD, Tziomalos K. Clinical relevance of clopidogrel-proton pump inhibitors interaction. World J Gastrointest Pharmacol Ther. 2015 May 06;6(2):17-21. doi: 10.4292/wjgpt.v6.i2.17. PMID: 25949846; PMCID: PMC4419089.
Copy Download .nbib Format: NLM
Effect of Povidone-iodine Washing of Gastrointestinal Mucosa or Taking Proton Pump Inhibitors on Bacteremia after Endoscopic Ultrasonography-guided Fine Needle Aspiration.

Endoscopic ultrasound

Li N, Qi H, Liu Z, Ge N, Guo J, Wang G, Liu X, Wang S, Sun S.
PMID: 24949344
Endosc Ultrasound. 2012 Jul;1(2):90-5. doi: 10.7178/eus.02.007.

OBJECTIVE: Few studies have evaluated the risk of bacteremia and infectious complications after endoscopic ultrasonography-guided fine needle aspiration (EUS-FNA). Therefore, we aimed to study the frequency of bacteremia and search for a method to potentially reduce bacterial infection after...

Cite
Li N, Qi H, Liu Z, et al. Effect of Povidone-iodine Washing of Gastrointestinal Mucosa or Taking Proton Pump Inhibitors on Bacteremia after Endoscopic Ultrasonography-guided Fine Needle Aspiration. Endosc Ultrasound. 2012;1(2):90-5doi: 10.7178/eus.02.007.
Li, N., Qi, H., Liu, Z., Ge, N., Guo, J., Wang, G., Liu, X., Wang, S., & Sun, S. (2012). Effect of Povidone-iodine Washing of Gastrointestinal Mucosa or Taking Proton Pump Inhibitors on Bacteremia after Endoscopic Ultrasonography-guided Fine Needle Aspiration. Endoscopic ultrasound, 1(2), 90-5. https://doi.org/10.7178/eus.02.007
Li, Na, et al. "Effect of Povidone-iodine Washing of Gastrointestinal Mucosa or Taking Proton Pump Inhibitors on Bacteremia after Endoscopic Ultrasonography-guided Fine Needle Aspiration." Endoscopic ultrasound vol. 1,2 (2012): 90-5. doi: https://doi.org/10.7178/eus.02.007
Li N, Qi H, Liu Z, Ge N, Guo J, Wang G, Liu X, Wang S, Sun S. Effect of Povidone-iodine Washing of Gastrointestinal Mucosa or Taking Proton Pump Inhibitors on Bacteremia after Endoscopic Ultrasonography-guided Fine Needle Aspiration. Endosc Ultrasound. 2012 Jul;1(2):90-5. doi: 10.7178/eus.02.007. PMID: 24949344; PMCID: PMC4062215.
Copy Download .nbib Format: NLM
Small bowel ulcerative lesions are common in elderly NSAIDs users with peptic ulcer bleeding.

World journal of gastrointestinal endoscopy

Tsibouris P, Kalantzis C, Apostolopoulos P, Zalonis A, Isaacs PE, Hendrickse M, Alexandrakis G.
PMID: 25512771
World J Gastrointest Endosc. 2014 Dec 16;6(12):612-9. doi: 10.4253/wjge.v6.i12.612.

AIM: To determine the frequency of small bowel ulcerative lesions in patients with peptic ulcer and define the significance of those lesions.METHODS: In our prospective study, 60 consecutive elderly patients with upper gastrointestinal bleeding from a peptic ulceration (cases)...

Cite
Tsibouris P, Kalantzis C, Apostolopoulos P, et al. Small bowel ulcerative lesions are common in elderly NSAIDs users with peptic ulcer bleeding. World J Gastrointest Endosc. 2014;6(12):612-9doi: 10.4253/wjge.v6.i12.612.
Tsibouris, P., Kalantzis, C., Apostolopoulos, P., Zalonis, A., Isaacs, P. E., Hendrickse, M., & Alexandrakis, G. (2014). Small bowel ulcerative lesions are common in elderly NSAIDs users with peptic ulcer bleeding. World journal of gastrointestinal endoscopy, 6(12), 612-9. https://doi.org/10.4253/wjge.v6.i12.612
Tsibouris, Panagiotis, et al. "Small bowel ulcerative lesions are common in elderly NSAIDs users with peptic ulcer bleeding." World journal of gastrointestinal endoscopy vol. 6,12 (2014): 612-9. doi: https://doi.org/10.4253/wjge.v6.i12.612
Tsibouris P, Kalantzis C, Apostolopoulos P, Zalonis A, Isaacs PE, Hendrickse M, Alexandrakis G. Small bowel ulcerative lesions are common in elderly NSAIDs users with peptic ulcer bleeding. World J Gastrointest Endosc. 2014 Dec 16;6(12):612-9. doi: 10.4253/wjge.v6.i12.612. PMID: 25512771; PMCID: PMC4265959.
Copy Download .nbib Format: NLM
Wheat - Dependent Exercise-Induced Anaphylaxis Occurred With a Delayed Onset of 10 to 24 hours After Wheat Ingestion: A Case Report.

Allergy, asthma & immunology research

Rongfei Z, Wenjing L, Nan H, Guanghui L.
PMID: 24991463
Allergy Asthma Immunol Res. 2014 Jul;6(4):370-2. doi: 10.4168/aair.2014.6.4.370. Epub 2014 Jan 20.

Wheat-dependent exercise-induced anaphylaxis (WDEIA) usually occurs 1 to 4 hours after wheat ingestion and the pathophysiology of WDEIA remains unknown. It is recommended that WDEIA patients refrain from exercise for 4 to 6 hours after wheat ingestion. We report...

Cite
Rongfei Z, Wenjing L, Nan H, et al. Wheat - Dependent Exercise-Induced Anaphylaxis Occurred With a Delayed Onset of 10 to 24 hours After Wheat Ingestion: A Case Report. Allergy Asthma Immunol Res. 2014;6(4):370-2doi: 10.4168/aair.2014.6.4.370.
Rongfei, Z., Wenjing, L., Nan, H., & Guanghui, L. (2014). Wheat - Dependent Exercise-Induced Anaphylaxis Occurred With a Delayed Onset of 10 to 24 hours After Wheat Ingestion: A Case Report. Allergy, asthma & immunology research, 6(4), 370-2. https://doi.org/10.4168/aair.2014.6.4.370
Rongfei, Zhu, et al. "Wheat - Dependent Exercise-Induced Anaphylaxis Occurred With a Delayed Onset of 10 to 24 hours After Wheat Ingestion: A Case Report." Allergy, asthma & immunology research vol. 6,4 (2014): 370-2. doi: https://doi.org/10.4168/aair.2014.6.4.370
Rongfei Z, Wenjing L, Nan H, Guanghui L. Wheat - Dependent Exercise-Induced Anaphylaxis Occurred With a Delayed Onset of 10 to 24 hours After Wheat Ingestion: A Case Report. Allergy Asthma Immunol Res. 2014 Jul;6(4):370-2. doi: 10.4168/aair.2014.6.4.370. Epub 2014 Jan 20. PMID: 24991463; PMCID: PMC4077966.
Copy Download .nbib Format: NLM
Treatment and prevention of gastrointestinal bleeding in patients receiving antiplatelet therapy.

World journal of critical care medicine

Yasuda H, Matsuo Y, Sato Y, Ozawa S, Ishigooka S, Yamashita M, Yamamoto H, Itoh F.
PMID: 25685721
World J Crit Care Med. 2015 Feb 04;4(1):40-6. doi: 10.5492/wjccm.v4.i1.40. eCollection 2015 Feb 04.

Antiplatelet therapy is the standard of care for the secondary prevention of acute coronary syndrome and ischemic stroke, especially after coronary intervention. However, this therapy is associated with bleeding complications such as gastrointestinal bleeding, which is one of the...

Cite
Yasuda H, Matsuo Y, Sato Y, et al. Treatment and prevention of gastrointestinal bleeding in patients receiving antiplatelet therapy. World J Crit Care Med. 2015;4(1):40-6doi: 10.5492/wjccm.v4.i1.40.
Yasuda, H., Matsuo, Y., Sato, Y., Ozawa, S., Ishigooka, S., Yamashita, M., Yamamoto, H., & Itoh, F. (2015). Treatment and prevention of gastrointestinal bleeding in patients receiving antiplatelet therapy. World journal of critical care medicine, 4(1), 40-6. https://doi.org/10.5492/wjccm.v4.i1.40
Yasuda, Hiroshi, et al. "Treatment and prevention of gastrointestinal bleeding in patients receiving antiplatelet therapy." World journal of critical care medicine vol. 4,1 (2015): 40-6. doi: https://doi.org/10.5492/wjccm.v4.i1.40
Yasuda H, Matsuo Y, Sato Y, Ozawa S, Ishigooka S, Yamashita M, Yamamoto H, Itoh F. Treatment and prevention of gastrointestinal bleeding in patients receiving antiplatelet therapy. World J Crit Care Med. 2015 Feb 04;4(1):40-6. doi: 10.5492/wjccm.v4.i1.40. eCollection 2015 Feb 04. PMID: 25685721; PMCID: PMC4326762.
Copy Download .nbib Format: NLM
Changing patterns in the surgical treatment of perforated duodenal ulcer - single centre experience.

Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques

Budzyński P, Pędziwiatr M, Grzesiak-Kuik A, Natkaniec M, Major P, Matłok M, Stanek M, Wierdak M, Migaczewski M, Pisarska M, Budzyński A.
PMID: 26649091
Wideochir Inne Tech Maloinwazyjne. 2015 Sep;10(3):430-6. doi: 10.5114/wiitm.2015.54057. Epub 2015 Sep 11.

INTRODUCTION: Although the surgical treatment of patients with perforated duodenal ulcer is the method of choice, the introduction of effective pharmacotherapy has changed the surgical strategy. Nowadays less extensive procedures are chosen more frequently. The introduction of laparoscopic procedures...

Cite
Budzyński P, Pędziwiatr M, Grzesiak-Kuik A, et al. Changing patterns in the surgical treatment of perforated duodenal ulcer - single centre experience. Wideochir Inne Tech Maloinwazyjne. 2015;10(3):430-6doi: 10.5114/wiitm.2015.54057.
Budzyński, P., Pędziwiatr, M., Grzesiak-Kuik, A., Natkaniec, M., Major, P., Matłok, M., Stanek, M., Wierdak, M., Migaczewski, M., Pisarska, M., & Budzyński, A. (2015). Changing patterns in the surgical treatment of perforated duodenal ulcer - single centre experience. Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques, 10(3), 430-6. https://doi.org/10.5114/wiitm.2015.54057
Budzyński, Piotr, et al. "Changing patterns in the surgical treatment of perforated duodenal ulcer - single centre experience." Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques vol. 10,3 (2015): 430-6. doi: https://doi.org/10.5114/wiitm.2015.54057
Budzyński P, Pędziwiatr M, Grzesiak-Kuik A, Natkaniec M, Major P, Matłok M, Stanek M, Wierdak M, Migaczewski M, Pisarska M, Budzyński A. Changing patterns in the surgical treatment of perforated duodenal ulcer - single centre experience. Wideochir Inne Tech Maloinwazyjne. 2015 Sep;10(3):430-6. doi: 10.5114/wiitm.2015.54057. Epub 2015 Sep 11. PMID: 26649091; PMCID: PMC4653256.
Copy Download .nbib Format: NLM
GPR84 and TREM-1 Signaling Contribute to the Pathogenesis of Reflux Esophagitis.

Molecular medicine (Cambridge, Mass.)

Abdel-Aziz H, Schneider M, Neuhuber W, Meguid Kassem A, Khailah S, Müller J, Gamal Eldeen H, Khairy A, T Khayyal M, Shcherbakova A, Efferth T, Ulrich-Merzenich G.
PMID: 26650186
Mol Med. 2016 Aug;21(1):1011-1024. doi: 10.2119/molmed.2015.00098. Epub 2016 May 09.

Gastro-esophageal reflux disease (GERD) is one of the most common disorders in gastroenterology. Patients present with or without increased acid exposure indicating a nonuniform etiology. Thus, the common treatment with proton pump inhibitors (PPIs) fails to control symptoms in...

Cite
Abdel-Aziz H, Schneider M, Neuhuber W, et al. GPR84 and TREM-1 Signaling Contribute to the Pathogenesis of Reflux Esophagitis. Mol Med. 2016;21(1):1011-1024doi: 10.2119/molmed.2015.00098.
Abdel-Aziz, H., Schneider, M., Neuhuber, W., Meguid Kassem, A., Khailah, S., Müller, J., Gamal Eldeen, H., Khairy, A., T Khayyal, M., Shcherbakova, A., Efferth, T., & Ulrich-Merzenich, G. (2016). GPR84 and TREM-1 Signaling Contribute to the Pathogenesis of Reflux Esophagitis. Molecular medicine (Cambridge, Mass.), 21(1), 1011-1024. https://doi.org/10.2119/molmed.2015.00098
Abdel-Aziz, Heba, et al. "GPR84 and TREM-1 Signaling Contribute to the Pathogenesis of Reflux Esophagitis." Molecular medicine (Cambridge, Mass.) vol. 21,1 (2016): 1011-1024. doi: https://doi.org/10.2119/molmed.2015.00098
Abdel-Aziz H, Schneider M, Neuhuber W, Meguid Kassem A, Khailah S, Müller J, Gamal Eldeen H, Khairy A, T Khayyal M, Shcherbakova A, Efferth T, Ulrich-Merzenich G. GPR84 and TREM-1 Signaling Contribute to the Pathogenesis of Reflux Esophagitis. Mol Med. 2016 Aug;21(1):1011-1024. doi: 10.2119/molmed.2015.00098. Epub 2016 May 09. PMID: 26650186; PMCID: PMC4982478.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 1722 entries